 Oral enoximone therapy chronic heart failure placebo-controlled randomized trial Western Enoximone Study Group parallel study design patients New York Heart Association Functional class II III heart failure mg times day mg times day matching placebo patients digitalis and/or diuretics ventricular ejection fractions equal Exercise tests weeks treatment Enoximone increases exercise time treatment weeks weeks Left ventricular ejection fraction first dose enoximone weeks long-term therapy Heart failure symptoms physicians evaluations cardiac status enoximone therapy groups first weeks evaluation evaluations cardiac status placebo group Diuretic doses patients placebo Adverse events similar frequency placebo mg enoximone treatment groups mg enoximone incidence adverse events Mean heart rate ventricular ectopic activity different treatment limbs exercise tolerance ventricular function symptoms heart failure weeks Heart rate ventricular ectopic activity mortality rate